Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Planning Enforcement Response To DTC Ads Aired Last Weekend

This article was originally published in The Pink Sheet Daily

Executive Summary

Acting Commissioner Crawford has formed an "informal" task force to "see if there is a violation we can pursue." Erectile dysfunction ads are a particular sore point, Crawford indicates. Action could come before the end of the week.

You may also be interested in...



Cialis TV Commercials Move Romantic Images To The Background

New DTC spot for Lilly/Icos' erectile dysfunction agent features an on-air spokesman in the foreground discussing risk information.

Cialis TV Commercials Move Romantic Images To The Background

New DTC spot for Lilly/Icos' erectile dysfunction agent features an on-air spokesman in the foreground discussing risk information.

Late Night Viagra: Pfizer Supports Limiting Hours For Erectile Dysfunction DTC Ads

CEO McKinnell says he agrees with a proposal to limit broadcast commercials for erectile dysfunction agents to the hours of 10 p.m.-6 a.m. PhRMA says it cannot make product-specific recommendations in its forthcoming voluntary DTC guidelines but could urge that ads run at appropriate times to target a drug's indicated population.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS061806

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel